Delivery Order SPE2DB24D2011-SPE2DB25FBRPM
- Not listed
- The Defense Logistics Agency awarded a $10,590.03 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg on September 16, 2025, with an ultimate completion date of September 17, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion...
- The Defense Logistics Agency awarded a $32,846.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, with completion scheduled for September 17, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.62 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This non-competitive delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price pharmaceutical procurement contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.76 to AmerisourceBergen Drug Corp for 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $24,188.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $2,702.16. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $10,368.01. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg at a firm fixed price ceiling value of $1,601.60. This competitive award carries no set-aside designation and requires completion by September 10, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $10.9K delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,944.66 delivery order to AmerisourceBergen Drug Corp on June 21, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The contract represents a competitive award under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRPMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,613.70 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This contract employs a firm fixed price delivery order structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with extensive experience fulfilling Defense Logistics Agency requirements. The company's portfolio includes a wide range of pharmaceutical products and medical supplies spanning multiple therapeutic domains, from generic medications to specialty drugs and medical devices. This specific delivery order for Tamsulosin HCL—a medication used in urological treatment—reflects the company's ongoing role in supporting military healthcare systems and other federal government agencies through the DLA Troop Support Medical procurement vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/15/25 |